SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CELEGHINI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.265
AS - Asia 3.527
EU - Europa 1.882
SA - Sud America 620
AF - Africa 71
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 13.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.124
SG - Singapore 1.356
CN - Cina 863
BR - Brasile 495
VN - Vietnam 401
IT - Italia 355
DE - Germania 288
UA - Ucraina 284
TR - Turchia 256
HK - Hong Kong 248
PL - Polonia 230
GB - Regno Unito 200
FI - Finlandia 129
FR - Francia 99
RU - Federazione Russa 83
SE - Svezia 71
IN - India 69
CA - Canada 65
MX - Messico 53
BD - Bangladesh 51
ID - Indonesia 49
JP - Giappone 44
AR - Argentina 41
NL - Olanda 36
ES - Italia 31
ZA - Sudafrica 31
IQ - Iraq 30
EC - Ecuador 26
PK - Pakistan 26
SA - Arabia Saudita 19
CO - Colombia 16
BE - Belgio 14
UZ - Uzbekistan 14
MY - Malesia 13
VE - Venezuela 13
AT - Austria 11
PH - Filippine 11
AU - Australia 9
CL - Cile 9
IR - Iran 9
LT - Lituania 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
EG - Egitto 7
IL - Israele 7
NP - Nepal 7
AL - Albania 6
AZ - Azerbaigian 6
JO - Giordania 6
KE - Kenya 6
UY - Uruguay 6
CR - Costa Rica 5
DZ - Algeria 5
JM - Giamaica 5
KZ - Kazakistan 5
PY - Paraguay 5
RO - Romania 5
TH - Thailandia 5
BO - Bolivia 4
HN - Honduras 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BH - Bahrain 3
CY - Cipro 3
IE - Irlanda 3
KR - Corea 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
AO - Angola 2
BG - Bulgaria 2
CH - Svizzera 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
MD - Moldavia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BB - Barbados 1
BS - Bahamas 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
MM - Myanmar 1
Totale 13.369
Salva come PNG Salva come JPEG
Città #
Singapore 823
Woodbridge 820
Ashburn 782
Fairfield 712
San Jose 449
Houston 380
Jacksonville 332
Seattle 319
Chandler 306
Cambridge 305
Beijing 283
Santa Clara 260
Wilmington 246
Ann Arbor 245
Hong Kong 243
Warsaw 228
Izmir 138
Ferrara 129
Ho Chi Minh City 123
Los Angeles 111
Dallas 105
New York 103
Nanjing 96
Hanoi 84
Princeton 76
Boardman 65
Council Bluffs 63
Munich 61
Lauterbourg 60
Milan 49
Helsinki 48
Dearborn 41
San Diego 41
Tokyo 39
São Paulo 37
Jakarta 35
The Dalles 35
Nanchang 34
Shanghai 34
Columbus 33
Mexico City 32
Buffalo 31
Orem 30
London 28
Changsha 24
Shenyang 24
Bremen 23
Tianjin 23
Da Nang 22
Frankfurt am Main 22
Johannesburg 22
Montreal 22
Manchester 21
Turku 21
Chennai 20
Jinan 20
Denver 19
Mountain View 19
Chicago 18
Bologna 17
Jiaxing 17
Haiphong 16
Moscow 16
Falls Church 15
Hebei 15
Stockholm 15
Brooklyn 14
Toronto 14
Brussels 13
Dong Ket 13
Kunming 13
San Mateo 13
Zhengzhou 13
Biên Hòa 12
Boston 12
Hefei 12
Leawood 12
Poplar 12
Rio de Janeiro 12
San Francisco 12
Baghdad 11
Hải Dương 11
Phoenix 11
Quito 11
Amsterdam 10
Aprilia 10
Falkenstein 10
Norwalk 10
Redwood City 10
Washington 10
Ankara 9
Tappahannock 9
Tashkent 9
Atlanta 8
Auburn Hills 8
Brasília 8
Curitiba 8
Ottawa 8
Riyadh 8
Bắc Ninh 7
Totale 9.288
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 331
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 288
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
Neuronal dysfunction associated with cholesterol deregulation 266
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 265
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 242
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 228
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 227
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 222
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 218
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 216
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 212
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies 210
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 208
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 208
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 203
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 191
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 191
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells 182
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. 182
Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease 173
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients 166
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line 165
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 163
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 160
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 158
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 156
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 156
Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity? 155
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 155
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 154
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 150
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate 148
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells 147
In situ polymerase chain reaction technique revealed by flow cytometry as a tool for gene detection 145
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 143
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 142
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 139
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 137
In vivo and in vitro modulatory effect of human immunodeficiency virus type (HIV-1) Tat protein on protein kinase C activity. 137
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 135
Pre-eclampsia affects procalcitonin production in placental tissue 123
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 122
Differential effects of stromal derived factor-1 alpha (SDF-1alpha) on early and late stages of human megakaryocytic development. 121
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 120
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells 115
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 109
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 108
null 105
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 102
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 101
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 100
MitoQ is able to modulate apoptosis and inflammation 100
null 98
null 97
null 94
null 92
null 90
null 90
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 90
null 89
null 89
null 89
null 89
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells 89
null 88
null 88
null 88
Potential role of circulating microRNAs as early markers of preeclampsia 86
null 86
null 86
null 86
null 86
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 86
null 86
null 85
Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development 84
null 83
null 83
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 83
null 82
null 81
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival 81
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 81
null 81
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 80
null 78
null 76
null 76
null 76
null 76
Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease 74
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 71
null 66
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia 66
null 65
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 61
Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes 61
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 61
Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs erythroid cells 59
Totale 12.904
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 0 83
2021/2022617 21 39 30 26 50 51 41 40 33 73 64 149
2022/2023758 77 43 26 100 122 113 48 44 95 10 34 46
2023/2024359 59 46 12 11 10 49 21 30 7 19 10 85
2024/20251.772 42 25 136 70 240 134 96 107 297 164 260 201
2025/20264.740 471 236 434 610 685 319 541 277 416 564 151 36
Totale 13.563